R&D 

Copyright(c)2017 Qilu Pharmaceutical Co., Ltd. 鲁ICP备06006222号 Headquarter Address: 243 Gong Ye Bei Road, Jinan, Shandong 250100, CHINA

PRODUCTS

MANUFACTURING

NEWS

CONTACT US

ABOUT US

联系电话:400-809-1789

Search
Search

联系电话:400-809-1789

Biosimilars

●  First biological product launched in 1999

●  3 products launched, 2 have the largest market share in China

●  Focusing on research and commercialization of recombinant protein drugs

 from prokaryotic expression and mammalian cell expression

●  Robust pipeline comprising biosimilars and innovative biologics

●  Manufacturing facilities complying with cGMP requirements

●  Dosage forms: ampoules, vials, pre-filled syringes, etc

 

Qilu Biopharmaceutical Industrial Park 

QILU

 

●  Total construction area covers 800,000 m2

●  Being constructed in accordance with the requirements of USFDA cGMP/EU GMP

●  Phase I construction completed and manufacture commenced. Manufacturing facilities are available for production of:

   - Mammalian cell expression products
   - Prokaryotic cell expression products
   - Small molecule finished formulations

MANUFACTURING